J. Floege et al., Expression of interferon-inducible Mx-proteins in patients with IgA nephropathy or Henoch-Schonlein purpura, AM J KIDNEY, 33(3), 1999, pp. 434-440
Both viral infections and dysregulated cytokine synthesis have been implica
ted in the pathogenesis of immunoglobulin A nephropathy (IgAN) and Henoch-S
chonlein purpura (HSP), Mr proteins are specifically induced by type I inte
rferons (IFN-alpha, -beta, -omega) and are very sensitive in detecting, for
example, virus-induced, in vivo production of IFN-alpha/-beta, because the
biological half-life of Mx (similar to 3 days) markedly exceeds that of IF
N-alpha/-beta (20 to 90 minutes), Mr concentrations in leukocytes were meas
ured by enzyme-linked immunosorbent assay (ELISA) in 79 blood samples of 35
patients with IgAN and five with HSP. No patient showed symptoms of infect
ions at the time of the examination. Compared with normal leukocyte Mr conc
entrations (<2 mU/1,000 leukocytes), only 3 of 79 samples of IgAN/HSP patie
nts showed mildly elevated Mr concentrations (range, 2.2 to 3 mU/1,000 leuk
ocytes), By contrast, patients with increased endogenous IFN production (lu
pus erythematosus) or patients treated with IFN-alpha(2) showed leukocyte M
r concentrations of up to 35 mU/1,000 leukocytes, In patients with IgAN and
HSP, leukocyte Mr concentrations were not correlated with various clinical
parameters. Immunohistochemically, no renal Mr expression could be detecte
d in eight renal biopsy specimens of patients with various stages of IgAN,
whereas control specimens (skin of patients treated with IFN-(alpha 2)) sho
wed abundant cellular Mx expression, Furthermore, human mesangial cells in
vitro showed marked Mx production after exposure to IFN-alpha or IFN-beta.
We conclude that, in patients with IgAN/HSP, no evidence of an activation o
r dysregulation of the type I interferon system can be detected, (C) 1999 b
y the National Kidney Foundation, Inc.